VYOME HOLDINGS, INC. Earnings Per Share (Basic)
VYOME HOLDINGS, INC. (HIND) reported Earnings Per Share (Basic) of -$0.10 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- VYOME HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.10.
- VYOME HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.15.
- VYOME HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$3.12.
- VYOME HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$799.90.
- VYOME HOLDINGS, INC. earnings per share, basic for fiscal 2025 was -$4.86.
- VYOME HOLDINGS, INC. earnings per share, basic for fiscal 2024 was -$6001.39.
- VYOME HOLDINGS, INC. earnings per share, basic for fiscal 2023 was -$110.87.
- VYOME HOLDINGS, INC. earnings per share, basic for fiscal 2022 was -$108.90.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.10 10-Q · filed 2026-08-12 | -$0.24 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$0.15 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | -$4.86 10-K · filed 2026-03-18 | |||||||
| 2025-09-30 | -$3.12 10-Q · filed 2025-11-14 | -$10.00 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | -$799.90 10-Q · filed 2026-08-12 | -$2.25 10-Q · filed 2025-08-14 | -$1561.45 10-Q · filed 2026-08-12 | -$1.85 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | -$761.59 10-Q · filed 2026-05-12 | $18.98 10-Q · filed 2025-05-20 | ||||||
| 2024-12-31 | -$6001.39 10-K · filed 2026-03-18 | -$13.83 10-K · filed 2025-04-04 | ||||||
| 2024-09-30 | -$1419.10 10-Q · filed 2025-11-14 | -$3.11 10-Q · filed 2024-11-14 | -$356.71 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$2955.71 10-Q · filed 2025-11-14 | -$11.94 10-Q · filed 2024-11-14 | -$94.39 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-06-30 | -$91.56 10-Q · filed 2025-08-14 | -$0.06 10-Q · filed 2024-08-14 | -$1536.83 8-K · filed 2025-09-02 | -$0.16 10-Q · filed 2024-08-14 | -$55.03 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$100.60 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||
| 2024-03-31 | -$135.37 10-Q · filed 2025-05-20 | -$0.09 10-Q · filed 2024-05-15 | -$27.63 derived: net income ÷ weighted average shares · filed 2025-05-20 | -$65.28 derived: net income ÷ weighted average shares · filed 2025-05-20 | -$12.16 derived: net income ÷ weighted average shares · filed 2025-05-20 | |||
| 2023-12-31 | -$6.40 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$32.20 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$7.32 derived: net income ÷ weighted average shares · filed 2025-04-04 | -$110.87 10-K · filed 2025-04-04 | -$1.91 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$59.36 10-Q · filed 2024-11-14 | -$1.02 10-Q · filed 2023-11-09 | -$4.25 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$199.98 10-Q · filed 2024-11-14 | -$3.45 10-Q · filed 2023-11-09 | -$19.01 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$1.08 10-Q · filed 2024-08-14 | -$2.48 10-Q · filed 2024-08-14 | -$12.46 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$23.61 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||||
| 2023-03-31 | -$1.56 10-Q · filed 2024-05-15 | -$17.42 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$35.49 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$53.74 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$33.73 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$61.01 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$86.22 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$108.90 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$27.01 10-Q · filed 2023-11-09 | -$0.52 10-Q · filed 2022-11-14 | -$51.66 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$73.79 10-Q · filed 2023-11-09 | -$1.47 10-Q · filed 2022-11-14 | -$171.15 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||
| 2022-06-30 | -$24.45 10-Q · filed 2023-08-07 | -$0.50 10-Q · filed 2022-08-19 | -$46.37 10-Q · filed 2023-08-07 | -$0.94 10-Q · filed 2022-08-19 | -$147.53 derived: net income ÷ weighted average shares · filed 2023-08-07 | -$197.61 derived: net income ÷ weighted average shares · filed 2023-08-07 | ||
| 2022-03-31 | -$21.87 10-Q · filed 2023-05-15 | -$0.44 10-Q · filed 2022-05-23 | -$124.58 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$175.22 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$228.70 derived: net income ÷ weighted average shares · filed 2023-05-15 | |||
| 2021-12-31 | -$104.27 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$155.60 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$221.27 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$288.97 10-K · filed 2023-04-17 | -$5.00 10-K · filed 2022-04-08 | |||
| 2021-09-30 | -$50.13 10-K · filed 2023-04-17 | -$1.48 10-Q · filed 2021-11-12 | -$97.14 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$150.31 10-K · filed 2023-04-17 | -$2.51 10-Q · filed 2021-11-12 | -$31.21 derived: net income ÷ weighted average shares · filed 2023-04-17 | ||
| 2021-06-30 | -$42.70 10-K · filed 2023-04-17 | -$0.86 10-Q · filed 2022-08-19 | -$103.19 10-K · filed 2023-04-17 | -$2.07 10-Q · filed 2022-08-19 | -$12.75 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$11.24 derived: net income ÷ weighted average shares · filed 2023-04-17 | ||
| 2021-03-31 | -$61.88 10-K · filed 2023-04-17 | -$1.24 10-Q · filed 2022-05-23 | -$6.74 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$7.05 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$7.52 derived: net income ÷ weighted average shares · filed 2023-04-17 | |||
| 2020-12-31 | -$2.19 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$3.50 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$4.43 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$5.55 10-Q · filed 2022-11-14 | -$5.54 10-Q · filed 2021-11-12 | |||
| 2020-09-30 | -$1.32 10-Q · filed 2021-11-12 | -$2.25 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$3.36 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$0.93 10-Q · filed 2021-11-12 | -$2.04 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |